Elhízás: ki dolgozik rajta

Intézményenként egy kártya. Célpontra vagy országra szűkítheted a listát.

• Minden célpont
• GLP-1 172
• PPAR 0
• FTO 0
• AMPK 3
• GIP 20
• SGLT2 5
• STAT3 0
• SIRT1 0
• PI3K 0
• NRF2 0
• AKT 0
• mTOR 2
• NLRP3 3
• MAPK 0
• TP53 0
• TNF 0
• IL-6 1
• TLR4 0
• BDNF 2
• DPP-4 1
• JNK 0
• APOE 0
• ERK 0
• IL-17 1
• PTEN 0
• STING 0
• ACE2 0
• HIF-1 0
• PCSK9 0
• VEGF 0
• IL-1 0
• JAK 0
• PNPLA3 2
• YAP 0
• HMGB1 0
• CTNNB1 0
• HER2 0
• MMP-9 0
• PD-L1 0
• PINK1 0
• TFEB 0
• TREM2 0
• CCR5 0
• FGFR 0
• GPX4 0
• IGF1R 0
• IL-23 0
• METTL3 0
• PD-1 0
• STK11 0
• AR 0
• BCL-2 0
• CFTR 0
• COX-2 0
• HDAC 0
• EGFR 0
• HSP90 0
• MEK 0
• MYC 0
• PKM2 0

1+ intézményből 1, a friss publikációk és a nyitott vizsgálatok szerint rendezve. Ez nem minőségi rangsor.

Funded research projects that name this disease in their title, terms or summary and have not ended yet: who is funded, where, how much and until when. Organisations only; the funder's page has the details.

• NIH NIAID · F30

  The role of Aiolos in lung-resident CD8+ memory T cell programming.

  Ohio State University· Columbus, Egyesült Államok· 45 821 USD awarded in fiscal year 2026· until 2030. okt.

• NIH NICHD · F32

  Role of the Placental Intrinsic Clock as a Central Regulator of Endocrine Function and Offspring Growth

  University of Minnesota· Minneapolis, Egyesült Államok· 76 300 USD awarded in fiscal year 2026· until 2029. jún.

• NIH NIAID · F31

  Dysregulation of Aging Regulatory T-Cell Response in Autoimmune Disease

  Utah State Higher Education System--University of Utah· Salt Lake City, Egyesült Államok· 38 914 USD awarded in fiscal year 2026· until 2029. okt.

• NIH NIA · R01

  The effects of sleep and diet on glial function

  Texas A&m University· College Station, Egyesült Államok· 527 686 USD awarded in fiscal year 2026· until 2031. máj.

• NIH NIDDK · RC2

  Interorgan Genomic Atlas for Discovery of Bioenergetic Dynamics and Mechanisms of Time-Restricted Feeding

  Northwestern University· Chicago, Egyesült Államok· 1 641 136 USD awarded in fiscal year 2026· until 2031. jún.

• European Commission (Horizon Europe) · HORIZON-TMA-MSCA-PF-EF

  Elucidating the role of maternal nutrient stores in the metabolism of the preimplantation embryo (MaterMeta)

  Kobenhavns Universitet· Kobenhavn, Dánia· EU contribution 247 553 EUR· until 2029. aug.

  The disease is named only in the funder's project summary, not in the title.

• European Commission (Horizon Europe) · HORIZON-TMA-MSCA-PF-EF

  Studying the role of Tbx-3 expressing neurons during obesity and ageing (OBrAgeing)

  Institut National de la Sante Et de la Recherche Medicale· Paris, Franciaország· EU contribution 226 421 EUR· until 2029. aug.

• European Commission (Horizon Europe) · HORIZON-ERC

  Selective Sensory Vagal Interface: a bionic platform for internal organ modulation (VisceraLink)

  Medizinische Universitaet Wien· Wien, Ausztria· EU contribution 2 210 625 EUR· until 2031. dec.

  The disease is named only in the funder's project summary, not in the title.

• European Commission (Horizon Europe) · HORIZON-TMA-MSCA-DN

  Metabolic disease heterogeneity definition, prevention and remission with targeted interventions (MEDIculous REMeDy)

  Helmholtz Zentrum Muenchen Deutsches Forschungszentrum Fuer Gesundheit und Umwelt Gmbh· Neuherberg, Németország· EU contribution 4 437 236 EUR· until 2030. dec.· 11 countries

  The disease is named only in the funder's project summary, not in the title.

• European Commission (Horizon Europe) · HORIZON-TMA-MSCA-DN

  Bridging Chronobiology and Physiology through Expert Training (ChronoBridge)

  Ecole Polytechnique Federale de Lausanne· Lausanne, Svájc· EU contribution 3 885 022 EUR· until 2030. dec.· 9 countries

  The disease is named only in the funder's project summary, not in the title.

10 of 4113 running projects, newest first. Listed amounts together: 2,5 Mrd USD + 430,1 M EUR.

Sources: NIH RePORTER (U.S. National Institutes of Health, public domain) and CORDIS (European Commission, CC BY 4.0). Changes: filtered by disease, organisations matched to ROR.

Leállított, visszavont és felfüggesztett vizsgálatok, a szponzor által a regiszterben megadott okkal, szó szerint idézve.

• Visszavonták

  GLP-1 Receptor Agonists and Alzheimer's Disease: A Multi-National Target Trial Emulation

  NCT07677865· West China Hospital· Frissítve: 2026. okt. 16.

  “poor accrual and funding issues”A regiszter szövege, változtatás nélkül. Forrás

Vizsgálatok, amelyek regiszteradata szerint az egyéni résztvevői adatokat (IPD) megosztják.

• IGOB131 As A GLP-1 Modulator For Metabolic Disorders In Adults With Obesity

  NCT07884058· University of Yaounde 1· Forrás

• GLP-1 Receptor Agonists and Alzheimer's Disease: A Multi-National Target Trial Emulation

  NCT07677865· West China Hospital· Forrás

• Effect of Aqueous Extracts of Cissus Quadrangularis and Dichrostachys Glomerata on GLP-1 Concentration and DPP-4 Activity in Overweight and Obese Adults

  NCT06827002· University of Yaounde 1· Forrás

Publikációk erről a betegségről egy MeSH-módszerkifejezés szerint, például szekvenálási vagy képalkotó módszerre.

• Single-Cell Analysis 21
• Organoids 10
• Mendelian Randomization Analysis 180
• CRISPR-Cas Systems 7
• Gene Expression Profiling 144
• Sequence Analysis, RNA 10
• Whole Genome Sequencing 4
• Exome Sequencing 19
• Proteomics 127
• Metabolomics 191
• Mass Spectrometry 28
• Flow Cytometry 16
• Immunohistochemistry 41
• Xenograft Model Antitumor Assays 15
• Positron-Emission Tomography 26
• Magnetic Resonance Imaging 258
• Machine Learning 155
• Deep Learning 20
• Cohort Studies 1014
• Genome-Wide Association Study 203

• FEV1 mediates the effect of major depressive disorder on asthma phenotypes: Mendelian randomization.

  Medicine (Baltimore), 2026. nov.

• Regional Adipose Distribution Reveals Differential Genetic Risk Patterns for Cardiometabolic Diseases.

  J Am Heart Assoc, 2026. okt.

• Genetic Determinants of Circulating Adiponectin Levels, a Complex Multifactorial Intermediate Phenotype.

  Biomolecules, 2026. okt.

• Body mass index and type 2 diabetes liability in osteomyelitis and cellulitis: A cross-biobank Mendelian randomization study.

  Medicine (Baltimore), 2026. okt.

• From Genes to Diets: A Critical Review of Genetic, Nutrigenomic and Epigenetic Mechanisms in Type 2 Diabetes Mellitus.

  Nutrients, 2026. szept.

• Multivariate GWAS framework for family trios with parental phenotypes to control dynastic effects.

  BMC Bioinformatics, 2026. szept.

• Diagnostic Approach to Genetic Obesity in Children: From Pathophysiology to Precision Medicine-A Narrative Review.

  Medicina (Kaunas), 2026. szept.

• Multivariate Genome-Wide Association Analysis Identifies Genetic Susceptibility Loci for Metabolic Syndrome in the Korean Genome and Epidemiology Study.

  Int J Mol Sci, 2026. szept.

• Integrative analysis prioritizes proteins associated with renal cell carcinoma and its risk factors.

  JNCI Cancer Spectr, 2026. szept.

• New Genetic Associations Between Alzheimer's Disease and Its Key Risk Factors.

  Psychogeriatrics, 2026. szept.

Megmutatjuk, a betegség mely célpontjait említi az absztrakt, és onnan a rajtuk dolgozókhoz jutsz.